PreveCeutical develops proprietary method for extracting cannabinoids for Sol-gel



PreveCeutical Medical INC. (CSE:PREV) CEO and President Stephen Van Deventer joined Steve Darling in the Vancouver studio …

Be the first to comment

Leave a Reply

Your email address will not be published.


*